KIMBERLY BARNHILL: Open Payments
NPI 1902179195 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 55 payments from 12 companies in 2025. Trend: 2023 $226 · 2024 $410 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $388 |
| Janssen Biotech, Inc. | 11 | $139 |
| Madrigal Pharmaceuticals | 4 | $80 |
| PFIZER INC. | 3 | $56 |
| Ardelyx, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Gilead Sciences, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: RINVOQ, TREMFYA, LINZESS, REZDIFFRA, IBSRELA, VELSIPITY, Wegovy, ENTYVIO.
Industry payments across FL — which companies pay providers there.
